Novo Nordisk Strengthens Semaglutide Defense with Real-World Data as Pipeline Awaits Judgment
Novo Nordisk unveils real-world evidence challenging Eli Lilly’s tirzepatide, advances CagriSema and Zenagamtide, and slashes Wegovy price for…
Browsing Tag